NASDAQ · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · SMALL CAP
OmniAb, Inc. OABI
5 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in OmniAb, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 4 March 2026. Every sentence was checked against that document before publication.
Growth
USD 18.7M
Revenue, FY2025 · full 5-year series below
Revenue $M
Net income $M
FY2025 · Revenue 18.7 · Net income -64.8
Compound annual growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−347 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating -369.5% · Net -347.0%
ROE
FY2025 · ROE -23.4%
Each USD of equity lost 23 cents this year.
The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Operating income $B | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 |
| EBITDA $B | −0.0 | −0.1 | −0.0 | −0.0 | −0.0 |
| Income tax $B | −0.0 | −0.0 | −0.0 | −0.0 | −0.0 |
| Net income $B | −0.1 | −0.1 | −0.1 | −0.0 | −0.0 |
| Free cash flow $B | −0.0 | −0.0 | 0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.57 | −0.61 | −0.51 | −0.26 | −0.33 |
| Dividend / sh $ | · | · | · | · | · |
| Payout % | · | · | · | · | · |
| ROE % | −23.4 | −20.6 | −15.4 | −7.8 | −11.5 |
| Shares out B | 0.14 | 0.12 | 0.12 | 0.12 | 0.00 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 21 reconciliationsAUDITED
Reconciled in 6 of 19 fiscal years. 55 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Commercial Physical & Biological Research
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2007